RecruitingNot ApplicableNCT07012135

Deciphering Preserved Autonomic Function After Multiple Sclerosis


Sponsor

Mayo Clinic

Enrollment

13 participants

Start Date

Sep 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study looks to characterize gradients of dysfunction in the autonomic nervous system in patients with clinically diagnosed multiple sclerosis. The autonomic nervous system plays key roles in regulation of blood pressure, skin blood flow, and bladder health- all issues that individuals with multiple sclerosis typically suffer. Focusing on blood pressure regulation, the most precise metric with broad clinical applicability, the investigators will perform laboratory-based tests to probe the body's ability to generate autonomic responses. For both individuals with multiple sclerosis and uninjured controls, laboratory-based experiments will utilize multiple parallel recordings to identify how the autonomic nervous system is able to inhibit and activate signals. The investigators anticipate that those with autonomic dysfunction with multiple sclerosis will exhibit abnormalities in these precise metrics. The investigators will look to see if any substantial connections exist between different degrees of preserved autonomic function and secondary autonomic complications from multiple sclerosis. In accomplishing this, the investigators hope to give scientists important insights to how the autonomic nervous system works after multiple sclerosis and give physicians better tools to manage these secondary autonomic complications.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how multiple sclerosis (MS) affects the body's automatic (autonomic) nervous system — the system that controls heart rate, blood pressure, and other involuntary functions — and whether some protective function is preserved despite the disease. **You may be eligible if...** - You are 18–50 years old - You have a confirmed diagnosis of multiple sclerosis, OR you are a healthy person volunteering as a comparison participant **You may NOT be eligible if...** - You have cardiovascular problems such as high blood pressure, stroke history, or chest pain - You have peripheral nerve disease, diabetes, or other autonomic disorders - You are pregnant or currently breastfeeding - Your BMI is 35 or above - You are taking medication known to affect heart rate or blood pressure regulation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTTests of sympathetic inhibition

Bolus phenylephrine infusion using the Oxford technique will generate the need to inhibit sympathetic activity. Similarly, resting state Mayer waves will be assessed with regard to heart rate and blood pressure responses.

DIAGNOSTIC_TESTTests of sympathetic activation

Cold pressor test of the hand will be used to cause sympathetic activation. Valsalva's maneuver will assess the ability to buffer against blood pressure fall (phase II).

DIAGNOSTIC_TESTTesting of autonomic dysreflexia

Cold pressor test of the foot and bladder pressor response will be tested.


Locations(1)

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07012135


Related Trials